Agilon Health, Inc.
AGL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $2 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $2 | $1 |
| Revenue | $1 | $1 | $2 | $2 |
| % Growth | 2.9% | -9% | 0.7% | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | -5.2% | -3.8% | 3.3% | -2.5% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -7.1% | -6.8% | 0.4% | -6.3% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -7.7% | -7.5% | 0.8% | -6.9% |
| EPS Diluted | -0.266 | -0.25 | 0.03 | -0.26 |
| % Growth | -6.4% | -933.3% | 111.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |